111 related articles for article (PubMed ID: 9814968)
1. Intracellular signaling leads to the hypertrophic effect of neuropeptide Y.
Goldberg Y; Taimor G; Piper HM; Schlüter KD
Am J Physiol; 1998 Nov; 275(5):C1207-15. PubMed ID: 9814968
[TBL] [Abstract][Full Text] [Related]
2. Early response kinase and PI 3-kinase activation in adult cardiomyocytes and their role in hypertrophy.
Schlüter KD; Simm A; Schäfer M; Taimor G; Piper HM
Am J Physiol; 1999 May; 276(5):H1655-63. PubMed ID: 10330251
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptors.
Pellieux C; Sauthier T; Domenighetti A; Marsh DJ; Palmiter RD; Brunner HR; Pedrazzini T
Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1595-600. PubMed ID: 10660688
[TBL] [Abstract][Full Text] [Related]
4. Activation of extracellular signal regulated protein kinase by neuropeptide Y and pancreatic polypeptide in CHO cells expressing the NPY Y(1), Y(2), Y(4) and Y(5) receptor subtypes.
Mullins DE; Zhang X; Hawes BE
Regul Pept; 2002 Apr; 105(1):65-73. PubMed ID: 11853873
[TBL] [Abstract][Full Text] [Related]
5. The signal transduction pathway causing the synergistic hypertrophic effects of neuropeptide Y and norepinephrine on primary cardiomyocyte.
Zeng C; Zhou Y; Liu G; Sun W
Neuropeptides; 2001; 35(5-6):211-8. PubMed ID: 12030804
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y Y1 and Y2 receptor-mediated stimulation of mitogen-activated protein kinase activity.
Nie M; Selbie LA
Regul Pept; 1998 Sep; 75-76():207-13. PubMed ID: 9802411
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y modifies the hypertrophic response of adult ventricular cardiomyocytes to norepinephrine.
Kanevskij M; Taimor G; Schäfer M; Piper HM; Schlüter KD
Cardiovasc Res; 2002 Mar; 53(4):879-87. PubMed ID: 11922898
[TBL] [Abstract][Full Text] [Related]
8. Role of phosphatidylinositol 3-kinase activation in the hypertrophic growth of adult ventricular cardiomyocytes.
Schlüter KD; Goldberg Y; Taimor G; Schäfer M; Piper HM
Cardiovasc Res; 1998 Oct; 40(1):174-81. PubMed ID: 9876330
[TBL] [Abstract][Full Text] [Related]
9. Characterization of neuropeptide Y-mediated corticotropin-releasing factor synthesis and release from human placental trophoblasts.
Robidoux J; Simoneau L; St-Pierre S; Masse A; Lafond J
Endocrinology; 2000 Aug; 141(8):2795-804. PubMed ID: 10919265
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of a variant HL60 cell line defective in the activation of the NADPH oxidase by phorbol myristate acetate.
Tardif M; Rabiet MJ; Christophe T; Milcent MD; Boulay F
J Immunol; 1998 Dec; 161(12):6885-95. PubMed ID: 9862721
[TBL] [Abstract][Full Text] [Related]
11. Possible roles of neuropeptide Y Y3-receptor subtype in rat aortic endothelial cell proliferation under hypoxia, and its specific signal transduction.
Chen ZY; Feng GG; Nishiwaki K; Shimada Y; Fujiwara Y; Komatsu T; Ishikawa N
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H959-67. PubMed ID: 17400722
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y inhibits beta-adrenergic agonist- and vasoactive intestinal peptide-induced cyclic AMP accumulation in rat pinealocytes through pertussis toxin-sensitive G protein.
Harada Y; Okubo M; Yaga K; Kaneko T; Kaku K
J Neurochem; 1992 Dec; 59(6):2178-83. PubMed ID: 1359017
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y stimulates hypertrophy of adult ventricular cardiomyocytes.
Millar BC; Schlüter KD; Zhou XJ; McDermott BJ; Piper HM
Am J Physiol; 1994 May; 266(5 Pt 1):C1271-7. PubMed ID: 8203492
[TBL] [Abstract][Full Text] [Related]
14. Induction of hypertrophic responsiveness of cardiomyocytes to neuropeptide Y in response to pressure overload.
Bell D; Allen AR; Kelso EJ; Balasubramaniam A; McDermott BJ
J Pharmacol Exp Ther; 2002 Nov; 303(2):581-91. PubMed ID: 12388639
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide-Y stimulation of extracellular signal-regulated kinases in human erythroleukemia cells.
Keffel S; Schmidt M; Bischoff A; Michel MC
J Pharmacol Exp Ther; 1999 Dec; 291(3):1172-8. PubMed ID: 10565839
[TBL] [Abstract][Full Text] [Related]
16. Identification of two isoforms of mouse neuropeptide Y-Y1 receptor generated by alternative splicing. Isolation, genomic structure, and functional expression of the receptors.
Nakamura M; Sakanaka C; Aoki Y; Ogasawara H; Tsuji T; Kodama H; Matsumoto T; Shimizu T; Noma M
J Biol Chem; 1995 Dec; 270(50):30102-10. PubMed ID: 8530415
[TBL] [Abstract][Full Text] [Related]
17. Gi-mediated activation of mitogen-activated protein kinase (MAPK) pathway by receptor mimetic basic secretagogues of connective tissue-type mast cells: bifurcation of arachidonic acid-induced release upstream of MAPK.
Shefler I; Seger R; Sagi-Eisenberg R
J Pharmacol Exp Ther; 1999 Jun; 289(3):1654-61. PubMed ID: 10336565
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y enhances LHRH binding to rat gonadotrophs in primary culture.
Leblanc P; L'Héritier A; Rasolonjanahary R; Kordon C
Neuropeptides; 1994 Feb; 26(2):87-92. PubMed ID: 8170523
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y inhibition of calcium channels in PC-12 pheochromocytoma cells.
McCullough LA; Egan TM; Westfall TC
Am J Physiol; 1998 May; 274(5):C1290-7. PubMed ID: 9612216
[TBL] [Abstract][Full Text] [Related]
20. A novel mitogenic signaling pathway of bradykinin in the human colon carcinoma cell line SW-480 involves sequential activation of a Gq/11 protein, phosphatidylinositol 3-kinase beta, and protein kinase Cepsilon.
Graness A; Adomeit A; Heinze R; Wetzker R; Liebmann C
J Biol Chem; 1998 Nov; 273(48):32016-22. PubMed ID: 9822674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
